Valentina Ambrosini
Associate Professor, PhD
19.02.2022 | Session E | MDT Panel
- PET/CT in NEN
- PET/CT with FDG and non-FDG radiopharmaceuticals
- PET/CT in oncology
Reto Bale
Prof.
10.03.2022 | Session 4A | Speaker
- Stereotactic thermal ablation
- Image Fusion
Detlef Klaus Bartsch
Dr. med.
10.03.2022 | Session 4A | Chair
- Surgery of small intestine NEN and pNEN
- Surgery of anaplastic thyroid cancer
Eric Baudin
MD, PhD
19.02.2022 | Session D | Chair
10.03.2022 | Session 3A | Speaker
11.03.2022 | ENETS/INCA Symposium | Speaker
- Endocrine tumors
Jürgen Becker
MD, PhD
19.02.2022 | Session C | Speaker
- Merkel cell carcinoma
- Carcinogenesis
- Immunobiology
Emily Bergsland
Professor of Medicine
08.03.2022 | Session 2 | Chair
11.03.2022 | Session 5A | Speaker
- Novel therapies for neuroendocrine neoplasms
- Molecular characterization of G3 NENs
- Outcomes in patients with NENs
Allan Bloom
MD, FSIR, FCIRSE
19.02.2022 | Session E | MDT Panel
- Embolization techniques and applications
- Clinical applications of novel reverse thermoresponsive polymers
Ivan Borbath
Prof
19.02.2022 | Session E | MDT Panel
- Clinical research in pancreatic adenocarcinoma (PI of a randomized phase 2), in biliary tract cancer
- Former lead of the ENETS registry, current co-lead of the belgian registry "DNET"
Mette Borre
RD
11.03.2022 | Nurse Symposium | Speaker
- Neuroendocrine cancer
- Nutrition
- Quality of life for my patients
Catherine Bouvier
10.03.2022 | Session 3A | Speaker
11.03.2022 | ENETS/INCA Symposium | Chair & Speaker
- Neuroendocrine Cancers
- Education
- Advocacy
Tessa Brabander
MD, PhD
11.03.2022 | Session 5A | Speaker
- Peptide receptor radionuclide therapy
- Functional imaging
Andrea Califano
Dr.
09.03.2022 |Session 4 | Speaker
- Mechanisms of cancer initiation, progression, and drug sensitivity
- molecular determinants of pro-malignant tumor microenvironment subpopulations
- tissue reprogramming and transdifferentiation
Jaume Capdevila
MD, PhD
10.03.2022 | Session 1 | Speaker
Martyn Caplin
PROFESSOR
10.03.2022 | Session 2A | Speaker
11.03.2022 | ENETS/INCA Symposium | Speaker
- Translational Neuroendocrine Tumour Research - Mesenetric fibrosis/desmoplasia
- Peptide receptor expression in NETs
- Peptide Receptor Radioligand Therapy
Justo P. Castaño
Bs, MSc, PhD
08.03.2022 | Summary of sessions 1 & 2 | Speaker
- Deciphering the role of splicing and RNA biology in Pancreatic, GI and Lung NETs
- Somatostatin and its receptors in NETs
Jie Chen
Dr. Professor
08.03.2022 | Session 1 | Chair
- Therapeutic strategies of NETs
- Biomarkers of diagnostic or therapeutic interest in NETs
Anne Couvelard
MD, PhD
08.03.2022 | Session 1 | Chair
10.03.2022 | Session 1 | Chair & Speaker
- Pathological and molecular characteristics of high grade neuroendocrine neoplasms
- Molecular heterogeneity of neuroendocrine neoplasms
- Diagnostic, prognostic and theranostic biomarkers in neuroendocrine neoplasms
Joakim Crona
MD PhD
19.02.2022 | Session B | Speaker
- Neuroendocrine tumors
Domenico D'Ugo
Professor of Surgery, ESSO President
10.03.2022 | Session 4A | Speaker
- Upper GI Cancer
- Mini-Invasive surgery
- New Surgical technologies
Wouter W. De Herder
MD PhD
19.02.2022 | Session C | Chair
10.03.2022 | Session 2B | Chair
- Fibrosis and NET
- PRRT
- Therapy of NET
Louis de Mestier
MD, PhD
19.02.2022 | Session B | Speaker
- Predictive and theranostic biomarkers in neuroendocrine tumors
- Clinicopathological and molecular characterization of tumor heterogeneity in neuroendocrine tumors
- Inherited predispositions to digestive neuroendocrine tumors
Cristina Dopazo
PhD
10.03.2022 | Session 4A | Speaker
- Liver Transplantation
- Cholangiocarcinoma
- Neuroendocrine Tumor Metastases
Michel Ducreux
11.03.2022 | Session 5A | Speaker
- Gastroenteropancreatic Neuroendocrine Tumours
- Drug Therapy
Sugandha Dureja
Dr
11.03.2022 | ENETS/INCA Symposium | Speaker
- Theranostics for NETs and Prostate cancer
- Ac 225 Alpha therapy for advanced NETs
- Ga68- FAPI based imaging and therapy- exploring their role in Phaeochromocytomas/Paragangliomas
Antongiulio Faggiano
MD, PhD
11.03.2022 | Session 7 | Speaker
- Molecular mechanisms of disease progression in NEN: NGS analysis of blood samples
- Clinical study on therapy with somatostatin analogues in NEN and sequence of treatments
- Clinical study on quality of life in NEN (endocrine-metabolic profile, nutrition, psyschological aspects)
Massimo Falconi
19.02.2022 | Session A | Chair
- Pancreatic surgery
- Neuroendocrine GEP NEN
- Pancreatic ductal adenocarcinoma
Jenny Falkerby
R:N research coordinator
19.02.2022 | Session E | MDT Panel
11.03.2022 | Nurse Symposium | Speaker
- Immunotherapy
- Oncolytic virus
- FIM / Phase 1trials
Nicola Fazio
M.D., Ph.D.
11.03.2022 | Session 5A | Chair & Speaker
- Neuroendocrine neoplasms
- Upper GI cancers
- Hepato-pancreato-biliary cancers
Ulla Feldt-Rasmussen
Professor
19.02.2022 | Session B | Speaker
- Multiple endocrine neoplasias
- Neuroendocrine tumours at large (e.g pituitary, adrenal, hereditary, medullary thyroid cancer)
Pier Luigi Filosso
Prof.
19.02.2022 | Session A | Speaker
- Thoracic Surgery
- Surgical management of Lung and Thymic Neuroendocrine tumors
Andrea Frilling
Professor
19.02.2022 | Session E | MDT Panel
- Multimodal treatment of advanced NEN
- Small bowel NEN
- Precision oncology / novel biomarkers
Rocio Garcia-Carbonero
MD, PhD
10.03.2022 | Session 4A | Chair
11.03.2022 | Session 6 | Speaker
- New drug development in NETs and NECs
- Development of biomarkers in NENs
- Translational research
Wanda Geilvoet
11.03.2022 | Nurse Symposium | Chair
- Outpatient clinic for patients with neuroendocrine tumors and other endocrine cancers, patient coordinator and contact person
- Active member tumor board for endocrine tumors and closely involved with the ENETS Center of Excellence audits
- Chair of ENETS Nurse & Dietician Group and member of medical advisory panel INCA
Simona Glasberg
Professor
11.03.2022 | Session 7 | Speaker
- Enhancers and neuroendocrine neoplasms
- The role of cannabinoids in neuroendocrine neoplasms
- Autophagy and neuroendocrine neoplasms
Enrique Grande
MD
19.02.2022 | Session C | Speaker
10.03.2022 | Session 1 | Chair
11.03.2022 | ENETS/INCA Symposium | Speaker
- Biomarkers
- Wearable devices and health
- Artificial intelligence
Julien Hadoux
MD, PhD
19.02.2022 | Session C | Speaker
- Neuroendocrine carcinoma
- Precision medicine
- Anaplastic thyroid carcinoma
Douglas Hanahan
PhD
08.03.2022 | Oral abstract presentations - Part II | Chair
09.03.2022 | Session 3 | Speaker
- Genetically engineered mouse models of human cancer
- Pancreatic Neuroendocrine Tumors
Daria Handkiewicz-Junak
MD
11.03.2022 | Session 7 | Speaker
- Thyroid cancer in childhood
- Radionuclide therapy of endocrine maligancies
Rod Hicks
Prof
09.03.2022 | Session 3 | Speaker
- Peptide receptor radionuclide therapy combinations
- NET genomics
- Preclinical models
Xianxin Hua
Professor of Cancer Biology
09.03.2022 | Session 4 | Speaker
- Basic and translational research on neuroendocrine tumors
- Cancer immunology and therapy
- Cancer biology
Robert T. Jensen
Dr
11.03.2022 | Session 8 | Speaker
- Gastrinomas
- Neuroendocine tunmor biology
- Cellular/pharmacological basis of GI hormone action
Yuchen Jiao
MD PhD
09.03.2022 | Session 3 | Speaker
- Pancreatic Neuroendocrine Tumor
- Cancer genomics and functional genomics
Nancy Joseph
Associate Professor
08.03.2022 | Session 2 | Speaker
- Cancer genetics
- Neuroendocrine carcinoma
- Integrated molecular and histologic subtyping of cancers
Gregory Kaltsas
Professor
19.02.2022 | Session B | Chair
- Inherited Endocrine Syndromes
- Bone metastases in neuroendocrine tumors
- Gastric Neuroendocrine neoplasms
Kenta Kawasaki
MD,PhD
08.03.2022 | Session 1 | Speaker
- Neuroendocrine cancer
- Organoids
Barbara Kiesewetter
19.02.2022 | Session D | Speaker
- Treatment landscape of NEN patients in Austria
- Molecular and clinical characterization of lung NET
- Molecular and clinical characterization of epNEN G3 (NEC vs NET)
Günter Klöppel
11.03.2022 | Life Achievement Award | Recipient
- High grade NENs
- Heterogeneity in pulmonary NENs
- NEN mimickers
Ulrich Knigge
MD, DMSc
19.02.2022 | Session A | Speaker
- Epidemiology of NEN
- Diagnosis of NEN
- Treatment of NEN
Teodora Kolarova
11.03.2022 | Nurse Symposium | Speaker / ENETS/INCA Symposium | Speaker
Grace Kong
Associate Professor
10.03.2022 | Session 2A | Speaker
- Molecular Imaging
- Radionuclide Therapy
- Combination therapy and clinical trials
Beata Kos-Kudła
11.03.2022 | Session 7 | Chair
- Biomarkers inNET
- Diagnosis and treatment of GEP NET
- Lung NET
Anna Koumarianou
MD PhD
19.02.2022 | Session E | MDT Panel
11.03.2022 | Session 6 | Chair
- Lung Neuroendocrine Tumors
- miRNA biomarkers
- Clinical Trials in high-grade tumors
B.A. Krishna
MD
09.03.2022 | Session 4 | Chair
- NET/PET in NETs
- Pulmonary carcinoids
- CHEMO-IMMUNO PRRT in NET
Jolanta Kunikowska
MD, PhD
19.02.2022 | Session D | Chair
- Theranostic application in nuclear medicine
- Radionuclide therapy
- New target in nuclear medicine
Angela Lamarca
MD, PhD, MSc
11.03.2022 | Session 5A | Speaker
- Systemic treatment for NENs
- Development of predictive and prognostic biomarkers in NENs
- Management of carcinoid syndrome and associated complications
Simone Leyden
11.03.2022 | ENETS/INCA Symposium | Speaker
- HCP Education – Development and dissemination of accredited online education for primary health and nurses
- Shared Care models – NET nurses and primary healthcare (GPs)
- Optimal Care Pathway – Development of first Australian Optimal Care Pathway for Neuroendocrine Tumours –Supported by the Australian government
Wendy Martin
MSc, BSc (hons), RGN
11.03.2022 | Nurse Symposium | Chair & Speaker
- Quality of Life
- Carcinoid heart disease
- Education
Mark McDonnell
11.03.2022 | ENETS/INCA Symposium | Speaker
- Patient advocacy and engagement
- Treatment options
- Patient pathway
Massimo Milione
MD, PhD
19.02.2022 | Session D | Speaker
- Gastroenteropancreatic neuroendocrine neoplasms (NET-NEC)
- Lung neuroendocrine tumors and carcinomas
- NET-NEC molecular analysis
Cristina Müller
PhD, PD
09.03.2022 | Session 4 | Speaker
- Radiotheragnostics
- Terbium radioisotopes for nuclear imaging and targeted radionuclide therapy
- Design and evaluation of radiolabeled tumor-targeting peptides and small molecules
Lise Munk Plum
11.03.2022 | Nurse Symposium | Chair
Bruno Niederle
Prof. Dr.
19.02.2022 | Session B | Chair & Speaker
- Endocrine Surgery (Thyroid/Parathyroid-Adrenal-Gastrointesinalpancreatic Neuroendocrine Tumors)
Els Nieveen van Dijkum
Prof Dr
10.03.2022 |Session 4A | Speaker
- Pancreatic NET - Risk stratification for recurrence, wait and see in small pNET, surgical outcomes and Quality of Life
- Small bowel NET - Surgical approach, fluorescence, treatment planning
- Training and education - Training residents and surgeons, nurses and patients
Dermot O'Toole
MD
19.02.2022 | Session E | Chair
10.03.2022 | Session 3A | Chair
Kjell Öberg
MD.PhD. Professor
09.03.2022 | Session 4 | Chair
10.03.2022 | Session 3B | Chair
- Biomarkers in NET
- Immunotherapy
- Radiotherapy
Francesco Panzuto
MD, PhD
19.02.2022 | Session D | Speaker
- Gastric Neuroendocrine Neoplasia
- NEN epidemiology (national registry - database)
- Prognostic features and risk factros for NEN progression
Andreas Pascher
MD, PhD
19.02.2022 | Session D | Speaker
- MJC EBNEN
- Liver Surgery for NEN liver metastasis
- GI NEN
Marianne Pavel
Prof. Dr.
19.02.2022 | Session D | Speaker
09.03.2022 | Summary of the day | Speaker
11.03.2022 | Session 5A | Chair / ENETS/INCA Symposium | Chair & Speaker / Life Achievement Award | Speaker
- Precision oncology in NEN
- Novel targeted treatment in NEN
- High grade NEC
Aurel Perren
Prof
19.02.2022 | Session E | MDT Panel
08.03.2022 | Session 2 | Chair
10.03.2022 | Session 3B | Chair / Poster session – Basic science | Chair
- The role of epigenetics and metabolism in the progression of Pancreatic Neuroendocrine Tumors (PanNET)
- Tumoroids / Organoids as models for PanNET
- Pathological and molecular classification of endocrine tumors
Vikas Prasad
10.03.2022 | Session 2A | Chair
- PET/CT, PET/MRI
- Radioligand Therapy
- Clinical Research
Dawn Quelle
PhD
08.03.2022 | Session 1 | Speaker
- Identification and characterization of pathways driving NET pathogenesis
- Role of RABL6A-PP2A signaling in NET metastasis
- Pre-clinical studies of novel combination therapies for NETs
Nitya Raj
MD
11.03.2022 | Session 6 | Speaker
- Molecular characterization of NENs
- New therapy development for NENs
- Identification of predictive and prognostic NEN biomarkers
John Ramage
Professor
11.03.2022 | Session 3A | Chair
- Quality of life and symptoms scores in neuroendocrine tumours of the small bowel and liver
- Rectal NET endoscopic therapy
- UK NET registry data epidemiology
Rachel Riechelmann
Dr
19.02.2022 | Session E | Chair
11.03.2022 | Session 6 | Speaker
- Clinical trials of NET
- Carcinoid syndrome
Anja Rinke
PD Dr
11.03.2022 | Session 5A | Speaker
- GEP NEN, clinical trials, prognostic parameters
- Lung NETs
Michel Rivoire
MD, PhD,
10.03.2022 | Session 4A | Speaker
- HPB surgery
- Surgical Oncology
- Ablation of liver metastases
Michael Rosenberg
10.03.2022 | Session 3A | Speaker
- Diet eBooks
- Israeli NET Lives Annual Congresses
Anguraj Sadanandam
PhD
08.03.2022 | Session 2 | Speaker
10.03.2022 | Poster session – Basic science | Chair
- Genomics
- Personalised Medicine
- Immunotherapy
Ramon Salazar
MD, PhD
11.03.2022 | Session 5A | Speaker
- SEQTOR Clinical Trial
- SEQTOR Aancilliary Studies
- Biomarkers & new molecular therapeutics
Hironobu Sasano
Professor
08.03.2022 | Oral abstract presentations - Part I | Chair
09.03.2022 | Session 4 | Chair
- Endocrine Pathology
- Neuroendocrine neoplasm
Aldo Scarpa
Professor of Pathology
08.03.2022 | Session 2 | Speaker
- Molecular profiling of NET entity subgroups
- Tumor biology
Ramesh Shivdasani
MD, PhD
08.03.2022 | Session 2 | Speaker / Oral abstract presentations - Part I | Chair
- Neuroendocrine cell differentiation
- Transcriptional and epigenetic control mechanisms
Simron Singh
Dr
08.03.2022 | Session 1 | Chair
10.03.2022 | Session 2B | Chair / Session 3A | Speaker
- Clinical Trials
- Patient Centered Care
- Health Services Reserach
Halfdan Sorbye
Prof
10.03.2022 | Session 1 | Speaker
- Gastroenteropancreatic neuroendocrine carcinoma
Stefan Stättner
Prof Dr
10.03.2022 | Session 4A | Chair
11.03.2022 | ENETS/INCA Symposium | Speaker
- Pancreatic Neoplasms
- NET liver metastases
- The role of surgery and clinical prognostication
Anders Sundin
MD PhD Prof
11.03.2022 | Session 7 | Chair
- 11C-hydroxy-ephedrine-PET/CT in pheochromocytoma and paraganglioma
- 68Ga-DOTATOC-PET/MRI
- Optimization of PRRT
Morten Hiul Suppli
MD, PhD
19.02.2022 | Session E | MDT Panel
- Multidisciplinary treatment of metastatic spinal cord compression
- Stereotactic radiotherapy of oligometastasis to the bone
- Hypofractionated proton therapy in fragile patients with locally advanced NSCLC
Espen Thiis-Evensen
PhD
10.03.2022 | Session 3A | Speaker
- Neuroendocrine neoplasm epidemiology
- Pancreatic neuroendocrine tumors
- Liver transplantation in neuroendocrine tumors
Eva Tiensuu Janson
MD PhD
19.02.2022 | Session A | Chair
11.03.2022 | ENETS/INCA Symposium | Speaker / Session 8 | Speaker
- Small intestinal NETS
- Neuroendocrine carcinomas
- Genetics
Christos Toumpanakis
MD, PhD, FRCP, AGAF, FEBGH
19.02.2022 | Session A | Speaker
10.03.2022 | Session 4B | Chair / Poster session – Clinical science | Chair
- Carcinoid Heart Disease
- Novel blood and imaging biomarkers
- Mesenteric fibrosis
Juan Valle
MD
19.02.2022 | Session D | Speaker
11.03.2022 | Session 6 | Chair
- Neuroendocrine tumours (clinical research)
- Biliary tract cancer
- Pancreatic cancer
Marie-Louise van Velthuysen
MD, PhD
- Classification of NEN G3
Chris Verslype
Professor
19.02.2022 | Session C | Chair
- Neuroendocrine tumours
- Hepatocellular carcinoma
- Biliopancreatic cancer
Irene Virgolini
Univ.-Prof. Dr.
10.03.2022 | Session 2A | Chair
- Oncolgoy, Theranostics
Thomas Walter
PhD, MD
10.03.2022 | Session 1 | Speaker
- Systemic treatments of NEN
- Leading some clinical trials (NIPINEC, BEVANEC, MGMT-NET...)
- Metastatic lung carcinoid tumors
Wolfgang Weber
Prof. Dr.
10.03.2022 | Session 2A | Speaker
- Molecular Imaging
- Theranostics
- PET/CT
Staffan Welin
MD,PhD
19.02.2022 | Session E | MDT Panel
- PRRT
- GEPNETS
- MEN1
Bertram Wiedenmann
Prof. Dr. med.
08.03.2022 | Oral abstract presentations - Part II | Chair
09.03.2022 | Session 3 | Chair
- Molecular profiling of NET entity subgroups
- Clinical trials
- Tumor and cell biology
James Yao
Professor and Chair, Department of Gastrointestinal Medical Oncology
10.03.2022 | Opening session | Speaker
- Targeted therapy
- Epidemiology
Hong Zhao
M.D.
09.03.2022 | Session 3 | Chair
- Surgical treatment for GEP-NET
- Translational research for NEN